Literature DB >> 15205361

Identification of a functional variant of estrogen receptor beta in an African population.

Chunyan Zhao1, Li Xu, Michio Otsuki, Gudrun Toresson, Konrad Koehler, Qiang Pan-Hammarström, Lennart Hammarström, Stefan Nilsson, Jan-Ake Gustafsson, Karin Dahlman-Wright.   

Abstract

In this study, we identified five novel polymorphisms in the estrogen receptor beta (ERbeta) gene in an African population. Interestingly, two of these variants are expected to change the amino acid sequence of the ERbeta protein. These changes correspond to an isoleucine to valine substitution at amino acid position 3 (I3V) and a valine to glycine substitution at position 320 (V320G), respectively. The functional consequences of these amino acid substitutions were determined in different in vitro assays. The I3V mutation displayed no differences with regard to transcriptional activity in a reporter assay, as compared with the wild-type receptor. The V320G mutation, however, showed significantly decreased maximal transcriptional activity in a reporter assay, although its binding affinity for 17beta-estradiol was not affected. A pull-down assay indicated that the interaction of full-length TIF2 with hERbetaV320G was weaker than with hERbetawt. Moreover, surface plasmon resonance analysis revealed reduced interaction of the V320G ERbeta variant with the NR box I and II modules of TIF2. To our knowledge, this represents the first identification of a functional polymorphism in the ERbeta gene. This novel polymorphism provides a tool for human genetic studies of diseases in the African population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205361     DOI: 10.1093/carcin/bgh215

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  Microarray analysis of altered gene expression in ERbeta-overexpressing HEK293 cells.

Authors:  Chunyan Zhao; Milica Putnik; Jan-Ake Gustafsson; Karin Dahlman-Wright
Journal:  Endocrine       Date:  2009-08-13       Impact factor: 3.633

2.  Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?

Authors:  Stephanie L Nott; Yanfang Huang; Brian R Fluharty; Anna M Sokolov; Melinda Huang; Cathleen Cox; Mesut Muyan
Journal:  Curr Pharmacogenomics Person Med       Date:  2008-12-01

3.  Identification of a predictive biomarker for the beneficial effect of keishibukuryogan, a kampo (Japanese traditional) medicine, on patients with climacteric syndrome.

Authors:  Takao Namiki; Hiromi Sato; Yukari Matsumoto; Haruka Kakikura; Koichi Ueno; Atsushi Chino; Hideki Okamoto; Akito Hisanaga; Akiyo Kaneko; Toshiaki Kita; Maki Kihara; Makio Shozu; Katsutoshi Terasawa
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-20       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.